XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity (Deficit) (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity under the Plans

Stock option activity under the Plans for the six months ended June 30, 2022 was as follows:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value

 

Balance—December 31, 2021

 

 

23,000,872

 

 

$

5.62

 

 

 

6.81

 

 

$

436,630

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,873,688

)

 

 

4.00

 

 

 

 

 

 

 

Canceled

 

 

(637,691

)

 

 

6.85

 

 

 

 

 

 

 

Balance—June 30, 2022

 

 

19,489,493

 

 

$

5.82

 

 

 

6.34

 

 

$

174,531

 

Options vested

 

 

13,493,649

 

 

$

3.85

 

 

 

5.65

 

 

$

139,755

 

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

RSU activity for the six months ended June 30, 2022 was as follows:

 

 

 

Number of
Shares

 

 

Weighted-Average
Grant Fair Value

 

 

Aggregate
Intrinsic
Value

 

Unvested balance—December 31, 2021

 

 

7,387,288

 

 

$

29.68

 

 

$

180,545

 

Granted

 

 

6,538,162

 

 

 

19.36

 

 

 

 

Released

 

 

(722,365

)

 

 

30.28

 

 

 

 

Forfeited

 

 

(717,931

)

 

 

30.42

 

 

 

 

Unvested balance—June 30, 2022

 

 

12,485,154

 

 

$

24.20

 

 

$

177,039

 

 

Summary of Stock-Based Compensation Expense in the Consolidated Statements of Operations

Stock-based compensation expense for the three and six months ended June 30, 2022 and 2021 is classified in the unaudited condensed consolidated statements of operations as follows:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cost of revenue

 

$

812

 

 

$

903

 

 

$

1,389

 

 

$

1,010

 

Research and development

 

 

12,619

 

 

 

18,363

 

 

 

22,362

 

 

 

20,391

 

Sales and marketing

 

 

8,048

 

 

 

11,310

 

 

 

14,322

 

 

 

12,658

 

General and administrative

 

 

6,026

 

 

 

8,599

 

 

 

11,410

 

 

 

10,400

 

Total

 

$

27,505

 

 

$

39,175

 

 

$

49,483

 

 

$

44,459

 

Summary of Shares of Common Stock Reserved for Future Issuance The Company’s common stock reserved for future issuance was as follows:

 

 

 

As of

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Stock options outstanding

 

 

19,489,493

 

 

 

23,000,872

 

RSUs outstanding

 

 

12,485,154

 

 

 

7,387,288

 

Shares available for future grants

 

 

20,153,991

 

 

 

16,905,525

 

Total shares of common stock reserved

 

 

52,128,638

 

 

 

47,293,685